InXile Entertainment

InXile Entertainment is an American video game development company based in Newport Beach, California. The company was founded in 2002 by Brian Fargo, who was previously the founder of Interplay Entertainment. InXile Entertainment is known for developing role-playing games (RPGs) and has a reputation for reviving classic game franchises.
History
InXile Entertainment was established in 2002 by Brian Fargo after he left Interplay Entertainment. The company's first project was The Bard's Tale, a reimagining of the classic 1985 game.
In 2012, InXile launched a successful crowdfunding campaign on Kickstarter for Wasteland 2, a sequel to the 1988 game Wasteland. The campaign raised nearly $3 million, significantly surpassing its initial goal. Wasteland 2 was released in 2014 to positive reviews.
Following the success of Wasteland 2, InXile launched another Kickstarter campaign for Torment: Tides of Numenera, a spiritual successor to Planescape: Torment. The campaign was also highly successful, raising over $4 million. Torment: Tides of Numenera was released in 2017.
In 2018, InXile was acquired by Microsoft and became part of Xbox Game Studios. This acquisition provided the company with additional resources and support for future projects.
Games Developed
- The Bard's Tale (2004)
- Hunted: The Demon's Forge (2011)
- Wasteland 2 (2014)
- Torment: Tides of Numenera (2017)
- The Bard's Tale IV: Barrows Deep (2018)
- Wasteland 3 (2020)
Notable Projects
Wasteland 2
Wasteland 2 is a post-apocalyptic RPG and a sequel to the 1988 game Wasteland. The game was funded through a successful Kickstarter campaign and released in 2014. It received positive reviews for its deep storytelling and complex gameplay mechanics.
Torment: Tides of Numenera
Torment: Tides of Numenera is a spiritual successor to Planescape: Torment. Set in the Numenera universe, the game focuses on narrative and player choice. It was funded through Kickstarter and released in 2017.
Wasteland 3
Wasteland 3 is the third installment in the Wasteland series. It was released in 2020 and features a cooperative multiplayer mode, a first for the series. The game was praised for its engaging story and improved gameplay mechanics.
Acquisition by Microsoft
In 2018, InXile Entertainment was acquired by Microsoft and became part of Xbox Game Studios. This acquisition allowed InXile to access more resources and support, enabling the development of more ambitious projects.
See Also
References
<references group="" responsive="1"></references>
External Links
This article is a video game corporation or company-related stub. You can help WikiMD by expanding it!
Ad. Transform your life with W8MD's Budget GLP-1 injections from $75


W8MD offers a medical weight loss program to lose weight in Philadelphia. Our physician-supervised medical weight loss provides:
- Weight loss injections in NYC (generic and brand names):
- Zepbound / Mounjaro, Wegovy / Ozempic, Saxenda
- Most insurances accepted or discounted self-pay rates. We will obtain insurance prior authorizations if needed.
- Generic GLP1 weight loss injections from $75 for the starting dose.
- Also offer prescription weight loss medications including Phentermine, Qsymia, Diethylpropion, Contrave etc.
NYC weight loss doctor appointmentsNYC weight loss doctor appointments
Start your NYC weight loss journey today at our NYC medical weight loss and Philadelphia medical weight loss clinics.
- Call 718-946-5500 to lose weight in NYC or for medical weight loss in Philadelphia 215-676-2334.
- Tags:NYC medical weight loss, Philadelphia lose weight Zepbound NYC, Budget GLP1 weight loss injections, Wegovy Philadelphia, Wegovy NYC, Philadelphia medical weight loss, Brookly weight loss and Wegovy NYC
|
WikiMD's Wellness Encyclopedia |
| Let Food Be Thy Medicine Medicine Thy Food - Hippocrates |
Medical Disclaimer: WikiMD is not a substitute for professional medical advice. The information on WikiMD is provided as an information resource only, may be incorrect, outdated or misleading, and is not to be used or relied on for any diagnostic or treatment purposes. Please consult your health care provider before making any healthcare decisions or for guidance about a specific medical condition. WikiMD expressly disclaims responsibility, and shall have no liability, for any damages, loss, injury, or liability whatsoever suffered as a result of your reliance on the information contained in this site. By visiting this site you agree to the foregoing terms and conditions, which may from time to time be changed or supplemented by WikiMD. If you do not agree to the foregoing terms and conditions, you should not enter or use this site. See full disclaimer.
Credits:Most images are courtesy of Wikimedia commons, and templates, categories Wikipedia, licensed under CC BY SA or similar.
Translate this page: - East Asian
中文,
日本,
한국어,
South Asian
हिन्दी,
தமிழ்,
తెలుగు,
Urdu,
ಕನ್ನಡ,
Southeast Asian
Indonesian,
Vietnamese,
Thai,
မြန်မာဘာသာ,
বাংলা
European
español,
Deutsch,
français,
Greek,
português do Brasil,
polski,
română,
русский,
Nederlands,
norsk,
svenska,
suomi,
Italian
Middle Eastern & African
عربى,
Turkish,
Persian,
Hebrew,
Afrikaans,
isiZulu,
Kiswahili,
Other
Bulgarian,
Hungarian,
Czech,
Swedish,
മലയാളം,
मराठी,
ਪੰਜਾਬੀ,
ગુજરાતી,
Portuguese,
Ukrainian